225 related articles for article (PubMed ID: 1737852)
1. Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.
Felix CA; Nau MM; Takahashi T; Mitsudomi T; Chiba I; Poplack DG; Reaman GH; Cole DE; Letterio JJ; Whang-Peng J
J Clin Invest; 1992 Feb; 89(2):640-7. PubMed ID: 1737852
[TBL] [Abstract][Full Text] [Related]
2. Absence of hereditary p53 mutations in 10 familial leukemia pedigrees.
Felix CA; D'Amico D; Mitsudomi T; Nau MM; Li FP; Fraumeni JF; Cole DE; McCalla J; Reaman GH; Whang-Peng J
J Clin Invest; 1992 Aug; 90(2):653-8. PubMed ID: 1644930
[TBL] [Abstract][Full Text] [Related]
3. Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma.
Felix CA; Kappel CC; Mitsudomi T; Nau MM; Tsokos M; Crouch GD; Nisen PD; Winick NJ; Helman LJ
Cancer Res; 1992 Apr; 52(8):2243-7. PubMed ID: 1559227
[TBL] [Abstract][Full Text] [Related]
4. [Alterations of the p53 gene and clinical features in childhood acute lymphoblastic leukemia].
Kawamua M; Hayashi Y; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Horibe K; Hongo T; Ueda K
Rinsho Ketsueki; 1997 Sep; 38(9):719-26. PubMed ID: 9364861
[TBL] [Abstract][Full Text] [Related]
5. A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm.
Felix CA; Strauss EA; D'Amico D; Tsokos M; Winter S; Mitsudomi T; Nau MM; Brown DL; Leahey AM; Horowitz ME
Oncogene; 1993 May; 8(5):1203-10. PubMed ID: 8479743
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family.
Schiffman JD; Chun N; Fisher PG; Dahl GV; Ford JM; Eggerding FA
Pediatr Blood Cancer; 2008 Apr; 50(4):914-6. PubMed ID: 17554785
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
Birch JM; Hartley AL; Tricker KJ; Prosser J; Condie A; Kelsey AM; Harris M; Jones PH; Binchy A; Crowther D
Cancer Res; 1994 Mar; 54(5):1298-304. PubMed ID: 8118819
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphoma.
Nomdedéu JF; Lete I; Baiget M; Lasa A; Estivill C; Rubiol E; Badell I; Pardo N; Cubells J; Mateu R; Brunet S; Bordes R; Soler J
Haematologica; 1997; 82(5):550-4. PubMed ID: 9407719
[TBL] [Abstract][Full Text] [Related]
10. A novel germ line p53 mutation in intron 6 in diverse childhood malignancies.
Avigad S; Barel D; Blau O; Malka A; Zoldan M; Mor C; Fogel M; Cohen IJ; Stark B; Goshen Y; Stein J; Zaizov R
Oncogene; 1997 Apr; 14(13):1541-5. PubMed ID: 9129144
[TBL] [Abstract][Full Text] [Related]
11. p53 mosaicism with an exon 8 germline mutation in the founder of a cancer-prone pedigree.
Kovar H; Auinger A; Jug G; Müller T; Pillwein K
Oncogene; 1992 Nov; 7(11):2169-73. PubMed ID: 1359493
[TBL] [Abstract][Full Text] [Related]
12. [Li-Fraumeni syndrome].
Frebourg T
Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
[TBL] [Abstract][Full Text] [Related]
13. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
Nakai H; Misawa S; Tanaka S; Nishigaki H; Taniwaki M; Yokota S; Horiike S; Takashima T; Seriu T; Nakagawa H
Leukemia; 1993 Oct; 7(10):1547-51. PubMed ID: 8412316
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma.
Toguchida J; Yamaguchi T; Dayton SH; Beauchamp RL; Herrera GE; Ishizaki K; Yamamuro T; Meyers PA; Little JB; Sasaki MS
N Engl J Med; 1992 May; 326(20):1301-8. PubMed ID: 1565143
[TBL] [Abstract][Full Text] [Related]
15. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.
Hussain SP; Amstad P; Raja K; Sawyer M; Hofseth L; Shields PG; Hewer A; Phillips DH; Ryberg D; Haugen A; Harris CC
Cancer Res; 2001 Sep; 61(17):6350-5. PubMed ID: 11522624
[TBL] [Abstract][Full Text] [Related]
16. Differentiation stages of childhood acute lymphoblastic leukemias with p53 mutations.
Felix CA; Wasserman R; Lange BJ; Brown DL; Nau MM; Cole DE; Minna JD; Poplack DG
Leukemia; 1994 Jun; 8(6):963-7. PubMed ID: 8207991
[TBL] [Abstract][Full Text] [Related]
17. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.
Lehman TA; Haffty BG; Carbone CJ; Bishop LR; Gumbs AA; Krishnan S; Shields PG; Modali R; Turner BC
Cancer Res; 2000 Feb; 60(4):1062-9. PubMed ID: 10706125
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
19. A germ line mutation in exon 5 of the p53 gene in an extended cancer family.
Law JC; Strong LC; Chidambaram A; Ferrell RE
Cancer Res; 1991 Dec; 51(23 Pt 1):6385-7. PubMed ID: 1933902
[TBL] [Abstract][Full Text] [Related]
20. Infrequent mutations in the P53 gene in primary human T-cell acute lymphoblastic leukemia.
Jonveaux P; Berger R
Leukemia; 1991 Oct; 5(10):839-40. PubMed ID: 1961018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]